OC
AXNX icon

Oakworth Capital’s Axonics, Inc. Common Stock AXNX Stock Holding History

Oakworth Capital’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-500
Closed -$13K – 597
2020
Q1 		$13K Buy
500
+304
+155% +$9.04K ﹤0.01% 364
2019
Q4 		$5K Hold
196
– – ﹤0.01% 480
2019
Q3 		$5K Buy
+196
New +$6.83K ﹤0.01% 484

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Polar Capital
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Oakworth Capital's AXNX Position: Q2 2020 in Review

Oakworth Capital sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2020, closing a stake of 500 shares — an estimated $13K sold.

Oakworth Capital first reported a position in AXNX in Q3 2019 and held it in 3 quarters. The position peaked at $13K in Q1 2020. 134 funds tracked by Wall St. Rank hold AXNX as of Q2 2020.

  • Oakworth Capital reported no remaining Axonics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Oakworth Capital sold 500 Axonics, Inc. Common Stock shares in Q2 2020, an estimated $13K.
  • Oakworth Capital first reported a position in Axonics, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
  • Oakworth Capital's Axonics, Inc. Common Stock position peaked at $13K in Q1 2020.
  • 134 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2020.

Based on Oakworth Capital's 13F filing for Q2 2020, filed 11 Aug 2020.